Previous 10 | Next 10 |
BMEZ is a CEF that pays monthly and yields 7.23%. It's trading at a 7.92% discount to NAV. It focuses on cutting-edge Life Sciences stocks and private investments. For further details see: BMEZ: We Own BME, But Here's Why We're Buying BlackRock Health Sciences Trust II ...
CEFs may be more susceptible to tax loss selling given they trade on a stock exchange and market prices (investor return) can deviate from underlying NAVs (fund return). Additionally, CEFs typically provide income to shareholders through monthly distributions. These dynamics may creat...
I put some capital to work through the month of November in 5 different funds. Black Friday wasn't just a day for shoppers in physical stores, but with the stock market decline, investors got a chance to snag some values too. The Omicron variant of COVID puts uncertainty in the ma...
BCAT was launched in September of 2020; the fund has moved to an attractive discount. On a NAV basis, the fund has performed reasonably well over the last year; that is what has opened up the attractive discount in the first place. The fund launched with a monthly distribution of ...
BlackRock Advisors, LLC announced today that the Boards of Directors/Trustees of six limited term BlackRock closed-end funds (the “Funds”) have authorized open market share repurchase programs (the “Repurchase Programs”) pursuant to which each Fund may repurc...
BlackRock is seeking to generate income and provide access to private markets using the “closed” fund structure. Closed-end funds have long been used for their income potential - for example, the average closed-end fund yields 6.3% 1 . Unlike other daily liquid funds, ...
This time last year, my most opportunistic subscribers took advantage of a rocky September and October— and secured annualized returns up to 117% with safe dividend plays . We have a similar setup this year, with the September swoon “refreshing” stocks-at-large ...
Market volatility has been ramping up throughout the month of September as historically it has been the weakest month. We are at historically narrow discounts/premiums for closed-end funds and that could mean things get even more volatile. Typically, staying the course and continu...
BMEZ's latest report shows significant realized gains, mostly enough to cover the distribution for the year, all else being equal. BMEZ is a fund focused on healthcare but allows exposure to small to mid-sized and private healthcare companies. The focus on these types of assets ca...
BIGZ was launched earlier this year and has since done a lot of nothing in terms of movement. The fund launched at a $20 NAV and last closed at $19.96, a large move with the prior close helped add $0.55 (August 27th). I view BIGZ as a long-term type holding that can provide income...
News, Short Squeeze, Breakout and More Instantly...
BlackRock Health Sciences Trust II of Beneficial Interest Company Name:
BMEZ Stock Symbol:
NYSE Market:
BlackRock Health Sciences Trust II of Beneficial Interest Website:
2024-07-12 05:00:04 ET With the market at nosebleed valuations, where can we look for value and yield? Let’s turn to our favorite three-letter acronym. C-E-Fs. As usual we have a handful of closed-end funds (CEFs) getting no love from Wall Street. This is perfect for ...
2024-07-10 03:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
The BlackRock closed-end funds (the “Funds”) listed below announced today the results of the Quarterly Measurement Period (as defined below) under their previously announced discount management programs (the “Programs”). Funds with a Trigger Event (as defined below) at...